<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00670787</url>
  </required_header>
  <id_info>
    <org_study_id>No. 19041</org_study_id>
    <nct_id>NCT00670787</nct_id>
  </id_info>
  <brief_title>Combination Pill of Losartan Potassium and Hydrochlorothiazide for Improvement of Medication Compliance Trial</brief_title>
  <acronym>COMFORT</acronym>
  <official_title>A Randomized Trial to Establish the Effects of Combination Pill of Losartan Potassium and Hydrochlorothiazide on Medication Compliance Among Patients With High Blood Pressure.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kyushu University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Kyushu University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to determine whether combination pill of losartan potassium and
      hydrochlorothiazide will improve medication compliance among patients with high blood
      pressure.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Despite clear evidence that blood pressure lowering treatment is beneficial for reduction of
      cardiovascular disease, blood pressure levels are not adequately controlled in many
      hypertensive patients. More intensive blood pressure lowering treatment is required to
      achieve maximum reduction of cardiovascular disease. Combination pills of blood pressure
      lowering drugs could be a safe and effective strategy to achieve blood pressure target but
      there is no randomized evidence that established the beneficial effects of combination pills
      of blood pressure lowering drugs. The purpose of the study is to determine whether
      combination pill of losartan potassium and hydrochlorothiazide will improve medication
      compliance among patients with high blood pressure.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2008</start_date>
  <completion_date type="Actual">February 2011</completion_date>
  <primary_completion_date type="Actual">November 2010</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Medication compliance</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Blood pressure</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>cost of blood pressure lowering drugs</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>serious adverse events</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>adverse events</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>blood test</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">207</enrollment>
  <condition>Hypertension</condition>
  <arm_group>
    <arm_group_label>Combination pill</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Combination pill of losartan potassium 50mg and hydrochlorothiazide 12.5mg in the morning</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>combination therapy of angiotensin receptor antagonists (losartan potassium 50mg, candesartan 8mg, valsartan 80mg, telmisartan 40mg or olmesartan 20mg) and thiazide or thiazide-like diuretics (hydrochlorothiazide 6.25-12.5mg, trichlormethiazide 0.5-1.0mg, indapamide 0.5-1.0mg or chlorthalidone 6.25-12.5mg)</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Combination pill of losartan and hydrochlorothiazide</intervention_name>
    <description>Combination pill of losartan potassium 50mg and hydrochlorothiazide 12.5mg in the morning</description>
    <arm_group_label>Combination pill</arm_group_label>
    <other_name>Preminent</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Aged 20 years or above

          -  Hypertension defined as blood pressure levels of &gt;/=140/90mmHg or current use of blood
             pressure lowering drugs

          -  Able to commence combination therapy of angiotensin receptor antagonists and diuretics

        Exclusion Criteria:

          -  Blood pressure measurements of &gt;/=200/120mmHg

          -  Previous serious adverse events due to angiotensin receptor antagonists or diuretics

          -  Known or possible pregnancy

          -  Known severe liver dysfunction

          -  Known severe kidney disease

          -  Known contraindication to angiotensin receptor antagonists or diuretics

          -  Taking &gt;/=4 tablets except for angiotensin receptor antagonists

          -  ACE inhibitors, thiazide or thiazide-like diuretics in the morning

          -  Current participation in another clinical trial

          -  A high likelihood that the patient is not suitable for the study treatment
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kiyoshi Matsumura, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Medicine and Clinical Science, Kyushu University</name>
      <address>
        <city>Fukuoka City</city>
        <state>Fukuoka</state>
        <zip>812-8582</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Japan</country>
  </location_countries>
  <verification_date>March 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 30, 2008</study_first_submitted>
  <study_first_submitted_qc>May 1, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 2, 2008</study_first_posted>
  <last_update_submitted>March 4, 2011</last_update_submitted>
  <last_update_submitted_qc>March 4, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 7, 2011</last_update_posted>
  <responsible_party>
    <name_title>Kiyoshi Matsumura</name_title>
    <organization>Department of Medicine and Clinical Science, Kyushu University</organization>
  </responsible_party>
  <keyword>Hypertension</keyword>
  <keyword>combination pill</keyword>
  <keyword>compliance</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertension</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Losartan</mesh_term>
    <mesh_term>Hydrochlorothiazide</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

